Better Therapeutics, Inc.
Better Therapeutics, Inc. (BTTX) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BTTX · as of Jun 8, 2026
Key Statistics
Explore Better Therapeutics, Inc. Data
bttx stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 2 · Buy rate: 100.0%
Competitors & Peers
bttx competitorsBTTX
AMPE
ARNI
BXRXQ
CALA
KLDOStock Performance
Full HistoryAbout Better Therapeutics, Inc.
Better Therapeutics, Inc. engages in developing software-based prescription digital therapeutics (PDT) platform candidates for treating diabetes, heart disease, and other cardiometabolic conditions in…
what is better therapeutics, inc. · bttx stock overview · better therapeutics, inc. company profile · who is better therapeutics, inc. ceo · bttx OTC · better therapeutics, inc. headquarters · better therapeutics, inc. business segments
About Stock Overview & Key Data
Better Therapeutics, Inc. (BTTX) is a Healthcare company in the Biotechnology industry, listed on OTC since Mar 17, 2021. As of the latest trading session, BTTX stock price is $0.00, with a market capitalization of $5,452. The stock has returned +0.00% over the past 12 months and +0.00% year-to-date.
According to 2 Wall Street analysts, the consensus rating for Better Therapeutics, Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2022, Better Therapeutics, Inc. reported revenue of — and net income of -$39.8M. For detailed data — including Better Therapeutics, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Better Therapeutics, Inc. (BTTX) stock price is $0.00. The stock is traded on OTC under the ticker symbol BTTX. The 52-week range is $0.00 – $0.00.